Evidence map›Paper›PMID 35676477›Full record

ArticleNature2022

Direct measurement of the

A Schneider, B Sikora, S Dickopf, M Müller, N S Oreshkina, A Rischka, I A Valuev, S Ulmer, J Walz, Z Harman and 3 more

Abstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

A SchneiderMax Planck Institute for Nuclear Physics, Heidelberg, Germany. antonia.schneider@mpi-hd.mpg.de.ORCID http://orcid.org/0000-0002-6780-5984
B SikoraMax Planck Institute for Nuclear Physics, Heidelberg, Germany.
S DickopfMax Planck Institute for Nuclear Physics, Heidelberg, Germany.
M MüllerMax Planck Institute for Nuclear Physics, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-7281-9002
N S OreshkinaMax Planck Institute for Nuclear Physics, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0814-3287
A RischkaMax Planck Institute for Nuclear Physics, Heidelberg, Germany.
I A ValuevMax Planck Institute for Nuclear Physics, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-1799-000X
S UlmerRIKEN, Ulmer Fundamental Symmetries Laboratory, Wako, Japan.ORCID http://orcid.org/0000-0002-4185-4147
J WalzInstitute for Physics, Johannes Gutenberg-University Mainz, Mainz, Germany.
Z HarmanMax Planck Institute for Nuclear Physics, Heidelberg, Germany.
C H KeitelMax Planck Institute for Nuclear Physics, Heidelberg, Germany.
A MooserMax Planck Institute for Nuclear Physics, Heidelberg, Germany.
K BlaumMax Planck Institute for Nuclear Physics, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-4468-9316

Funding

European Research Council
6 · The paper itself

Abstract

Helium-3 has nowadays become one of the most important candidates for studies in fundamental physics

Identifiers

PMID35676477
PMCPMC9242863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.